Calix, INC Form 4 insider transactions

NYSE
Calix CFO Cory Sindelar acquired 270 shares of common stock through the company's Employee Stock Purchase Plan at a price of $33.6855 per share.
NYSE
Calix President and CEO Michael Weening sold 74,000 shares of common stock for $57 per share after exercising options at $8.03, as part of a pre-arranged 10b5-1 trading plan.
NYSE
Carl Russo, a Director and 10% Owner of Calix, Inc. (CALX), sold 25,000 shares of common stock for approximately $1.38 million through a pre-arranged Rule 10b5-1 trading plan.
NYSE
Calix, Inc.'s Chief Financial Officer, Cory Sindelar, exercised stock options and simultaneously sold an equal number of common shares on July 23, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
Calix President and CEO Michael Weening sold 200,000 shares of common stock for over $11 million through pre-planned Rule 10b5-1 transactions after exercising stock options.
NYSE
Calix Director and 10% Owner Carl Russo was granted 11,561 stock options with an exercise price of $53.19, vesting annually over four years, as part of a pre-arranged Rule 10b5-1 plan.
NYSE
Calix, Inc.'s Chief Financial Officer, Cory Sindelar, exercised stock options and subsequently sold an equal number of common shares, as reported in a Form 4 filing.
NYSE
Calix, Inc. President and CEO Michael Weening exercised stock options and subsequently sold 100,000 shares of common stock for approximately $4.66 million, as reported in a recent SEC Form 4 filing.
NYSE
Director Carl Russo reports acquisition of restricted stock and stock options in Calix, Inc.
NYSE
Director Michael J. Berry reports acquisition of 4,689 shares of Calix, Inc. restricted stock.
NYSE
Kathleen M. Crusco, a director at Calix, Inc., was granted 4,689 shares of restricted stock on May 8, 2025, under the company's non-employee director equity compensation policy.
NYSE
Director Wade Oosterman reports the acquisition of 4,689 shares of Calix, Inc. stock and a correction to a previous filing regarding omitted shares.
NYSE
Director Rajatish Mukherjee reports acquiring 4,689 shares of Calix, Inc. restricted stock on May 8, 2025, as part of the company's non-employee director equity compensation policy.
NYSE
Director Kira Makagon reports acquiring 4,689 shares of Calix Inc. restricted stock on May 8, 2025, as part of the company's non-employee director equity compensation policy.
NYSE
Director Kevin Peters reports the acquisition of 4,689 shares of Calix stock and disposal of 130,717 shares.
NYSE
Christopher J. Bowick, a director at Calix, Inc., was granted 4,689 shares of restricted stock on May 8, 2025, according to a Form 4 filing with the SEC.
NYSE
Director Carl Russo of Calix, Inc. executed a sale of 25,000 shares of common stock at an average price of $39.5876 on April 28, 2025, according to a Form 4 filing.
NYSE
Director Carl Russo sold 25,000 shares of Calix, Inc. common stock at an average price of $38.15 on February 27, 2025, according to a Form 4 filing.
NYSE
Michael Weening, President and CEO of Calix, Inc., acquired 349 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) on February 14, 2025.
NYSE
Cory Sindelar, CFO of Calix, Inc., reports acquiring 387 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a price of $31.365 per share.
NYSE
Michael Weening, CEO of Calix, Inc., acquired stock options on January 31, 2025, following the achievement of performance criteria related to previously granted options.
NYSE
Calix's Chief Financial Officer, Cory Sindelar, received stock options after the company's Talent and Compensation Committee determined that certain performance criteria were met.
NYSE
Chief Product Officer of Calix, Shane Eleniak, reports acquisition of stock options following the achievement of performance criteria, as determined by the Talent and Compensation Committee.
NYSE
John Matthew Collins, Chief Commercial Ops Officer at Calix, Inc., was granted stock options after performance criteria were met, as determined by the Talent and Compensation Committee.
NYSE
Director Carl Russo sold 25,000 shares of Calix, Inc. common stock at an average price of $35.42 on November 4, 2024.
NYSE
Calix CEO Michael Weening reports the acquisition of common stock through the company's Employee Stock Purchase Plan (ESPP).
NYSE
Director Wade Oosterman acquired 7,317 stock options in Calix, Inc. on August 8, 2024, exercisable starting August 8, 2025.
NYSE
Carl Russo, a director and 10% owner of Calix, Inc., sold a portion of his holdings in multiple transactions on August 2, 2024, according to a Form 4 filing with the SEC.
NYSE
Director Carl Russo acquired 12,262 stock options in Calix, Inc. on May 9, 2024.
NYSE
Director Christopher J. Bowick reports the acquisition of stock options for Calix, Inc.